May 8 |
Penumbra, Inc. (NYSE:PEN) Q1 2024 Earnings Call Transcript
|
May 8 |
Penumbra (PEN) Q1 Earnings Lag Estimates, Margins Expand
|
May 8 |
Penumbra, Inc. (PEN) Q1 2024 Earnings Call Transcript
|
May 7 |
Penumbra Inc (PEN) Surpasses Analyst Revenue Forecasts in Q1 2024
|
May 7 |
Penumbra Non-GAAP EPS of $0.41 beats by $0.03, revenue of $278.7M beats by $4.2M
|
May 7 |
Penumbra, Inc. Reports First Quarter 2024 Financial Results
|
May 6 |
Penumbra Q1 2024 Earnings Preview
|
May 1 |
Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
|
Apr 24 |
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
|
Apr 23 |
Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots
|